Article
Denosumab stimulates spermatogenesis in infertile men with preserved Sertoli cell capacity
1 Oct 2024
Abstract excerpt
Sperm production depends on proper Sertoli-germ cell interaction, and we hypothesized that receptor activator of nuclear factor κB ligand (RANKL) activity in Sertoli cells may influence spermatogenesis. Treatment with the RANKL inhibitor denosumab, normally used to treat osteoporosis, increased testicular weight, inhibin B, and germ cell proliferation in ex vivo testis cultures and in vivo in a humanized RANKL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
